Transfusion-transmitted disease

Bailliere's Clinical Haematology

Volumn 9, Issue 2, 1996, Pages 369-394

  Lee, C A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; DIDANOSINE; RECOMBINANT ALPHA INTERFERON; ZALCITABINE; ZIDOVUDINE;

CREUTZFELDT JAKOB DISEASE; DELTA AGENT HEPATITIS; HEMOPHILIA; HEPATITIS; HEPATITIS A; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; LIVER TRANSPLANTATION; PARVOVIRUS; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS TRANSMISSION;

EID: 0029885453     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(96)80069-2     Document Type: Article

References (107)

1. Adamson JW Blaine Hollinger F Snyder EL Bianco C Challenges to transfusion medicine: infection and immunologic complications of blood transfusion Education Programme of ASH (Seattle) 1995 82 92
2. Anon Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. The Oral Ganciclovir European and Australian Cooperative Study Group AIDS 9 1995 471 477
3. Aronstam A Congard B Evans DI HIV infection in haemophilia—a European cohort Archives of Disease in Childhood 68 1993 521 524
4. Azzi A Ciappi S Zakvrzewska K Human parvovirus B19 infection in hemophiliacs first induced with two high-purity, virally attenuated factor VIII concentrates American Journal of Hematology 39 1992 228 230
5. Beeson PB Jaundice occurring one to four months after transfusion of blood or plasma: report of seven cases Journal of the American Medical Association 121 1943 1332 1334
6. Bontempo FA Lewis JH Gorenc TJ Liver transplantation in hemophilia A Blood 69 1987 1721 1724
7. Brackman HH Oldenberg J Eis-Hubinger AM Hepatitis A virus infection among the hemophilia population at the Bonn hemophilia center Vox Sanguinis 67 supplement 1 1994 3 8
8. Brackman SA Gerritzen A Oldenburg J Search for intrafamilial transmission of hepatitis C virus in hemophilia patients Blood 81 1993 1077 1082
9. Bresters D Mauser-Bunschoten EP Cuypers HTM Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2b treatment in haemophilia patients Scandinavian Journal of Gastroenterology 27 1992 166 168
10. Brettler DB Forsberg AD Levine PH Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies Blood 3 1989 1859 1863
11. Brettler DB Mannucci PM Gringeri A The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study Blood 80 1992 540 543
12. Centers for Disease Control Kaposi's Sarcoma and pneumocystis pneumonia among homosexual men—New York City and California MMWR 30 1981 306 308
13. Cheingsong-Popov R Panagiotidi C Bowcock S Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection British Medical Journal 302 1991 23 26
14. Chemello L Alberti A Rose K Simmonds P Hepatitis C serotype and response to interferon therapy New England Journal of Medicine 330 1994 143
15. Chorba TL Holman RC Strine TW Changes in longevity and causes of death among persons with hemophilia A American Journal of Hematology 45 1994 112 121
16. Colombo M Mannucci PM Brettler DB Hepatocellular carcinoma in hemophilia American Journal of Hematology 37 1991 243 246
17. Concorde Coordinating Committee Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection Lancet 343 1994 871 881
18. + cell counts greater than 400 per cubic millimeter New England Journal of Medicine 329 1993 297 303
19. Corsi B Azzi A Morfini N Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates Journal of Medical Virology 25 1988 165 170
20. Cossart YE Field AM Cant B Widdows D Parvovirus-like particles in human sera Lancet i 1975 72 73
21. Darby SC Rizza CR Doll R Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom British Medical Journal 298 1989 1064 1068
22. Darby SC Ewart DW Giangrande PLF Mortality before and after HIV infection in the complete UK population of haemophiliacs Nature 377 1995 79 82
23. DeArmond SJ Prusiner SB Etiology and pathogenesis of prion diseases American Journal of Pathology 146 1995 785 811
24. DeBiasi R Rocino A Miraglia E The impact of a very high purity Factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomised, prospective, two-year comparison with an intermediate purity concentrate Blood 78 1991 1919 1922
25. Decker CF Masur H Current status of prophylaxis for opportunistic infections in HIV-infected patients AIDS 8 1994 11 20
26. Devereux H Telfer P Dusheiko G Lee C Hepatitis C genotypes in haemophilic patients treated with alpha-interferon Journal of Medical Virology 45 1995 284 287
27. Di Bisceglie AM Martin P Kassianides C Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial New England Journal of Medicine 321 1989 1506 1510
28. Di Bisceglie AM Bacon BR Kleiner DE Hoofnagle JH Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C Journal of Hepatology 21 1994 1109 1112
29. Dolan G Viral interference in haemophilia Haemophilia 1 supplement 4 1995 13 14
30. Dourakis S Brown J Kumar U Serological response and detection of viraemia in acute hepatitis C virus infection Journal of Hepatology 14 1992 370 376
31. Dusheiko G Management of chronic hepatitis C Haemophilia 1 supplement 4 1995 30 35
32. Dusheiko G Schmilovitz-Weiss M Brown D Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease Hepatology 19 1994 13 18
33. Esmonde TFG Will RG Slattery JM Creutzfeldt-Jakob disease and blood transfusion Lancet 341 1993 205 207
34. Eyster ME Gail MH Ballard JO Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age Annals of Internal Medicine 107 1987 1 6
35. Eyster ME Alter HJ Aledort LM Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) Annals of Internal Medicine 115 1991 764 768
36. Eyster ME Diamondstone LS Lien JM Natural history of hepatitis C virus infection in multi-transfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study Journal of Acquired Immune Deficiency Syndromes 6 1993 602 610
37. Eyster ME Fried MW Di Bisceglie AM Goedert JJ Increasing hepatitis C virus RNA levels in haemophiliacs: relationship to human immunodeficiency virus infection and liver disease Blood 84 1994 1020 1023
38. Fischl MA Richman DD Grieco The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial New England Journal of Medicine 317 1987 185 191
39. Fletcher ML Trowell JM Craske J Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients British Medical Journal 287 1983 1754 1757
40. Flores G Juárez JC Montoro JB Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C viruses Haemophilia 1 1995 115 117
41. Gerritzen A Schneweis KE Brackmann HH Acute hepatitis A in haemophiliacs Lancet 340 1992 1231 1232
42. Goedert JJ Kessler CM Aledort LM A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia New England Journal of Medicine 321 1989 1141 1148
43. Goedert JJ Cohen AR Kessler CM Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate Lancet 344 1994 791 792
44. Goldsmith JM Deutsche J Tang M Green D CD4 cells in HIV-1 infected hemophiliacs: effects of factor VIII concentrates Thrombosis and Haemostasis 66 1991 415 419
45. Hallam NF Fletcher ML Read SJ Low risk of sexual transmission of hepatitis C virus Journal of Medical Virology 40 1993 251 253
46. Hanley JP Dolan G Day S Interaction of hepatitis B and hepatitis C infection in haemophilia British Journal of Haematology 85 1993 611 612
47. Harrison NA Skidmore SJ Neopterin and beta-2 microglobulin levels in asymptomatic HIV infection: the predictive value of combining markers Journal of Medical Virology 32 1990 128 133
48. Hilgartner MW Buckley JD Operskalski EA Purity of factor VIII concentrates and serial CD4 counts: the Transfusion Safety Group Lancet 34 1993 1373 1374
49. Hollinger FB Khan NC Oefinger PE Posttransfusion hepatitis type A Journal of the American Medical Association 250 1983 2313 2317
50. Huang YQ Li JJ Kaplan MH Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma Lancet 345 1995 759 761
51. Jarvis LM Ludlam CA Simmonds P Hepatitis C virus genotypes in multi-transfused individuals Haemophilia 1 supplement 4 1995 3 7
52. Kernoff PB Lee CA Karayiannis P Thomas HC High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin British Journal of Haematology 60 1985 469 479
53. Kolho E Naukkarinen R Ebeling F Transmission of hepatitis C virus to sexual partners of seropositive patients with bleeding disorders: a rare event Scandinavian Journal of Infectious Diseases 23 1991 667 670
54. Lee CA Hepatitis C and haemophilia British Medical Journal 310 1995 1619 1620
55. Lee CA Dusheiko G Hepatitis and haemophilia Zuckerman A Thomas HC Viral Hepatitis 1993 Churchill Livingstone Edinburgh 501 516
56. Lee CA Kernoff PB Karayiannis P Interactions between hepatotropic viruses in patients with haemophilia Journal of Hepatology 1 1985 379 384
57. Lee CA Phillips A Elford J The natural history of human immunodeficiency virus infection in a haemophilic cohort British Journal of Haematology 73 1989 228 234
58. Lee CA Webster A Griffiths PD Kernoff PB Symptomless HIV infection after more than ten years Lancet 335 1990 425 426
59. Lee CA Sabin CA Phillips AN Morbidity and mortality from transfusion-transmitted disease in haemophilia Lancet 345 1995 1309
60. Leissinger CA Andes WA Role of splenectomy in the management of hemophilic patients with human immunodeficiency virus-associated immunopathic thrombocytopenic purpura American Journal of Hematology 40 1992 207 209
61. Lemon SM Becherer PR Wang JG Hepatitis delta infection among multiple-transfused hemophiliacs Gerin JL The Hepatitis Delta Virus 1991 Wiley-Liss New York 351 360
62. Lim SG Lee CA Charman H Hepatitis C antibody assay in a longitudinal study of haemophiliacs British Journal of Haematology 78 1991 398 402
63. Lim SG Lee CA Hales M Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs Alimentary Pharmacology and Therapeutics 5 1991 199 205
64. Makris M Preston FE Triger DR A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs Blood 78 1991 1672 1677
65. Manuelidis EE Kim JH Mericangas JR Manuelidis L Transmission to animals of Creutzfeldt-Jakob Disease from human blood Lancet ii 1985 896 897
66. Mannucci PM Outbreak of hepatitis A among Italian patients with haemophilia Lancet 339 1992 819
67. Mannucci PM Gdovin S Gringeri A Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group Annals of Internal Medicine 120 1994 1 7
68. Mannucci PM Santagonstino E Di Bona E The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies Vox Sanguinis 67 supplement 1 1994 31 35
69. Mimms LT Mosley JW Hollinger FB Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection British Medical Journal 307 1993 1095 1097
70. Morfini M Longo G Rossi Ferrini P Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B19 parvovirus American Journal of Hematology 39 1992 149 150
71. Moyes CD Milne A Dimitrakakis M Very low dose hepatitis B vaccine in newborn infants: an economic option for control in endemic areas Lancet i 1987 29 30
72. Nishiguchi S Kuroki T Nakatani S Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis Lancet 346 1995 1051 1055
73. Peerlinck K Vermylen J Acute hepatitis A in patients with haemophilia A Lancet 341 1993 179
74. Peerlinck K Willems M Sheng L Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha 2-b interferon is not a predictor for sustained response to treatment British Journal of Haematology 86 1994 816 819
75. Phillips AN Lee CA Elford J p24 antigenaemia, CD4 lymphocyte counts and the development of AIDS AIDS 5 1991 1217 1222
76. Phillips AN Elford J Sabin C Immunodeficiency and the risk of death in HIV infection Journal of the American Medical Association 268 1992 2662 2666
77. Phillips AN Sabin CA Elford J Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection British Medical Journal 309 1994 309 313
78. Pillay D Pereira C Sabin C A long-term follow-up of hepatitis B vaccination in patients with congenital clotting disorders Vaccine 12 1994 978 983
79. Preston FE Jarvis LM Makris M Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease Blood 85 1995 1259 1262
80. Purcell RH Mannucci PM Gdovin S Virology of the hepatitis A epidemic in Italy Vox Sang 67 supplement 4 1994 2 7
81. Rabkin CS Hilgartner MW Hedberg KW Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia Journal of the American Medical Association 267 1992 1090 1094
82. Ragni MV Bontempo FA Myers DJ Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus-infected hemophiliacs Blood 75 1990 1267 1272
83. Ratnoff OD Menitove JE Aster RH Lederman MM Coincident classic hemophilia and ‘idiopathic’ thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII) New England Journal of Medicine 308 1983 439 442
84. Reichard O Andersson J Schvarcz R Weiland O Ribavirin treatment for chronic hepatitis C Lancet 337 1991 1058 1061
85. Rosina F Saracco G Rizzetto M Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study New England Journal of Medicine 312 1985 1488 1491
86. + counts before and after switching to monoclonal high-purity Factor VIII concentrate in HIV-infected haemophilic patients Thrombosis and Haemostasis 72 1994 214 217
87. Sabin CA Phillips AN Lee CA Beta-2 microglobulin as a predictor of prognosis in HIV-infected men with haemophilia: a proposed strategy for use in clinical care British Journal of Haematology 86 1994 366 371
88. Sabin CA Phillips AN Lee CA The effect of CMV infection on progression of human immunodeficiency virus disease in a cohort of haemophilic men followed for up to 13 years from seroconversion Epidemiology and Infection 114 1995 361 372
89. Sahmoud T Laurian Y Garzengel C Progression to AIDS in French haemophiliacs association with HLA-B35 AIDS 7 1993 497 500
90. Sato S Fugiyama S Tanaka M Coinfection of hepatitis C virus in patients with chronic hepatitis B infection Journal of Hepatology 21 1994 159 166
91. Scaraggi FA Lomuscio S Perricci A Intrafamilial and sexual transmission of hepatitis C virus (letter; comment) Lancet 342 1993 1300 1302
92. Schwart TF Roggendorf M Hottenträger B Removal of parvovirus B19 from contaminated factor VIII during fractionation Journal of Medical Virology 35 1991 28 31
93. Seremetis S Aledort LM Bergman G Three-year randomised study of high-purity or intermediate purity Factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status Lancet 342 1993 700 703
94. Sheretz RJ Russell BA Reuman PD Transmission of hepatitis A by transfusion of blood products Archives of Internal Medicine 144 1984 1579 1580
95. Simons JN Pilot-Matias TJ Leary TP Identification of two flavivirus-like genomes in the GB hepatitis agent Proceedings of the National Academy of Sciences USA 92 1995 3401 3405
96. Steel CM Ludlam CA Beatson D HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease Lancet i 1988 1185 1188
97. Telfer PT Sexual transmission of hepatitis C virus Haemophilia 1 supplement 4 1995 15 18
98. (Abstract 58) Telfer PT Devereux HL Goldman E Prevalence of HIV and hepatitis C virus infection in sexual partners of haemophilic patients British Journal of Haematology 84 supplement 1 1993
99. Telfer PT Brown D Devereux H HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients British Journal of Haematology 88 1994 397 399
100. Telfer PT Sabin C Devereux H The progression of HCV-associated liver disease in a cohort of haemophilic patients British Journal of Haematology 87 1994 555 561
101. Telfer PT Devereux H Savage K Chronic hepatitis C virus infection in haemophilic patients: clinical significance of viral genotype Thrombosis and Haemostasis 74 1995 1259 1264
102. Temperley IJ Cotter KP Walsh TJ Clotting factors and hepatitis A Lancet 340 1992 1466
103. Troisi CL Hollinger FB Hoots WK A multicenter study of viral hepatitis in a United States hemophilic population Blood 81 1993 412 418
104. Volberding PA Lagakos SW Koch MA Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter New England Journal of Medicine 322 1990 941 949
105. Wilde JT Rymes N Skidmore S Hepatitis A immunization in HIV-infected haemophilic patients Haemophilia 1 1995 196 199
106. Yee TT Lee CA Pasi KJ Life-threatening human parvovirus B19 infection in immunocompetent haemophilia Lancet 345 1995 794 795
107. Youle MS Gazzard BG Johnson MA Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study AIDS 8 1994 641 649